Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $6.1 Million - $10.6 Million
-1,020,979 Reduced 52.93%
908,107 $8.91 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $8.42 Million - $11.9 Million
844,702 Added 77.9%
1,929,086 $25.7 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $8.61 Million - $13 Million
1,084,384 New
1,084,384 $12.6 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $2.75 Million - $6 Million
700,000 New
700,000 $4.06 Million
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $4.26 Million - $6.66 Million
-221,439 Reduced 56.01%
173,885 $3.56 Million
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $8.35 Million - $11.8 Million
-336,029 Reduced 45.95%
395,324 $10.1 Million
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $9.06 Million - $14.6 Million
406,353 Added 125.03%
731,353 $25.6 Million
Q1 2021

May 17, 2021

SELL
$26.38 - $51.15 $13.8 Million - $26.8 Million
-523,216 Reduced 61.68%
325,000 $10.8 Million
Q4 2020

Feb 16, 2021

SELL
$10.5 - $28.5 $6.84 Million - $18.6 Million
-651,784 Reduced 43.45%
848,216 $22 Million
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $788,149 - $2.15 Million
218,324 Added 17.03%
1,500,000 $14.8 Million
Q3 2019

Nov 14, 2019

SELL
$4.99 - $6.16 $196,935 - $243,110
-39,466 Reduced 2.99%
1,281,676 $6.61 Million
Q2 2019

Nov 18, 2019

SELL
$5.92 - $7.41 $3.72 Million - $4.66 Million
-628,858 Reduced 32.25%
1,321,142 $7.99 Million
Q1 2019

Nov 18, 2019

SELL
$6.8 - $7.4 $1.85 Million - $2.02 Million
-272,385 Reduced 12.26%
1,950,000 $14.1 Million
Q4 2018

Nov 18, 2019

BUY
$3.99 - $7.82 $8.87 Million - $17.4 Million
2,222,385 New
2,222,385 $16.4 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.